KIF11 and neoplasm: Overall, our findings with ispinesib lay the foundation for future studies that could explore repeated and extended dosing of both KIF11 inhibition and radiotherapy to potentially achieve even great tumor cell death and further extension of survival if not, ideally, the full eradication of tumor burden.